Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and Diabetes Mellitus

raloxifene hydrochloride has been researched along with Diabetes Mellitus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, M; Huang, W; Wu, XC1
Barrett-Connor, E; Blackwell, T; Davidowitz, N; Kanaya, AM; Krueger, K; Yaffe, K1
Geiger, MJ; Wenger, NK1
Simorre, B1
Mayer, DF1

Other Studies

6 other study(ies) available for raloxifene hydrochloride and Diabetes Mellitus

ArticleYear
Raloxifene upregulated mesangial cell MMP-2 activity via ER-β through transcriptional regulation.
    Cell biochemistry and biophysics, 2013, Volume: 67, Issue:2

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Estrogen Receptor beta; Female; Gene Expression Regulation, Enzymologic; Matrix Metalloproteinase 2; Mesangial Cells; Mice; Protein Kinase Inhibitors; Raloxifene Hydrochloride; Tissue Inhibitor of Metalloproteinase-2; Transcription Factor AP-2; Transcription, Genetic; Up-Regulation

2013
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women.
    Neurology, 2004, Aug-24, Volume: 63, Issue:4

    Topics: Age Factors; Aged; Blood Glucose; Brain; Cardiovascular Diseases; Cognition Disorders; Comorbidity; Dementia; Depression; Diabetes Mellitus; Fasting; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Middle Aged; Obesity; Odds Ratio; Osteoporosis, Postmenopausal; Prediabetic State; Psychological Tests; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Tomography, X-Ray Computed

2004
Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
    Contemporary clinical trials, 2005, Volume: 26, Issue:6

    Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Lipids; Menopause; Middle Aged; Patient Selection; Raloxifene Hydrochloride; Risk Factors; Smoking

2005
[41th Congress of EASD (European Association for The Study of Diabetes) 10 to 15 September 2005, Athens, Greece].
    La Revue de medecine interne, 2006, Volume: 27, Issue:4

    Topics: Aged; Albuminuria; Antihypertensive Agents; Bone Density Conservation Agents; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Pioglitazone; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Spironolactone; Thiazolidinediones; Time Factors

2006
Raloxifene and prevention of vertebral fracture (cont'd): mainly when oestrogen is contraindicated.
    Prescrire international, 2000, Volume: 9, Issue:50

    Topics: Breast Neoplasms; Clinical Trials as Topic; Contraindications; Diabetes Mellitus; Estrogen Replacement Therapy; Female; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Spinal Fractures; Thromboembolism; Uterine Neoplasms

2000
Raloxifene and risk of cardiovascular events.
    JAMA, 2002, Jul-03, Volume: 288, Issue:1

    Topics: Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators

2002